Recent Company News

• 11:39 PM ET Jun 10, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (90 total)

• 10:56 PM ET Jun 10, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (49 total)

• 11:55 PM ET Jun 08, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (109 total)

• 11:11 PM ET Jun 08, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (78 total)

• 08:07 PM ET May 29, 2025
  

  China accepts Shionogi & Co's NDA of naldemedine tosilate for treatment of opioid-induced constipation (¥2408.0000, +20)

• 08:11 PM ET May 13, 2025
  

  Street Takeaways - Shionogi & Co. Q4 Earnings & acquisition of Torii Pharmaceutical

• 02:47 AM ET May 12, 2025
  

  Shionogi & Co. reports Q4 net income attributable ¥36.6B vs FactSet ¥42.83B [3 est, ¥35.72-55.37B] (¥2252.5000, 0)

• 02:53 AM ET May 07, 2025
  

  Shionogi & Co confirms launch of tender offer to acquire 45.2% stake in Torii Pharmaceutical for ¥6,350/share or ¥80.72B (¥5580.0000, 0)

• 01:48 AM ET May 07, 2025
  

  Shionogi & Co to acquire Torii Pharmaceutical for ¥150B - Nikkei (¥5580.0000, +350)

• 02:51 AM ET Apr 24, 2025
  

  Shionogi & Co. guides year-end dividend ¥33/share vs prior guidance ¥29/share (¥2385.0000, 0)